v3.26.1
Acquisition of Soleno Therapeutics, Inc. - Preliminary Allocation of Consideration Transferred to the Assets Acquired and Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2026
May 18, 2026
Mar. 31, 2026
Dec. 31, 2025
Business Combination [Line Items]        
Goodwill $ 500.6   $ 6.0 $ 6.1
Soleno Therapeutics, Inc.        
Business Combination [Line Items]        
Cash and cash equivalents   $ 471.3    
Accounts receivable   34.7    
Inventory   185.3    
Prepaid expenses and other current assets   9.0    
Intangible assets   2,237.8    
Right-of-use assets   4.6    
Accounts payable and accrued liabilities   (113.9)    
Operating lease liabilities   (4.6)    
Deferred tax liabilities   (489.4)    
Other assets and liabilities, net   0.5    
Total identifiable net assets acquired   2,335.3    
Goodwill   494.6    
Total assets acquired and liabilities assumed   $ 2,829.9